ELIZABETH KELLY: Open Payments
NPI 1750037693 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 8 payments from 7 companies in 2025. Trend: 2023 $277 · 2024 $82 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $135 |
| AtriCure, Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Fresenius USA Marketing, Inc. | 1 | $14 |
Products named: Wegovy, SYNERGY ABLATION SYSTEM, Vanrafia, ISTURISA, Dexcom G6 Transmitter, JARDIANCE, VELPHORO.
Industry payments across KS — which companies pay providers there.
